Skip to main content
HHS Logo U.S. Department of Health & Human Services NIH logo National Institutes of Health

Preclinical Innovation

This scanning electron microscope image shows SARS-CoV-2 (yellow)—also known as 2019-nCoV, the virus that causes COVID-19—isolated from a patient in the U.S., emerging from the surface of cells (blue/pink) cultured in the lab.
NCATS Seeks Applications to Facilitate COVID-19 Research Using CTSA Program-Supported Resources

NCATS Seeks Applications to Facilitate COVID-19 Research Using CTSA Program-Supported Resources

The effects of compounds on melanoma cells
Collaborating to Overcome Roadblocks to Advance Melanoma Therapy

NCATS scientists used high-throughput screening to help colleagues at NCI identify existing compounds and drugs that could lead to improvements in a therapy for a form of metastatic melanoma, a potentially deadly skin cancer.

Improving the Drug Development Process

Creating and testing innovative methods to improve and accelerate the drug development process and find new treatments for patients faster.

Repurposing Drugs

Discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside.

Testing & Predictive Models

Developing better model systems for drug and toxicity testing.

Core Technologies

Using state-of-the-art resources to enable the ongoing operation of all NCATS translational research activities.

Improving the Drug Development Process

Creating and testing innovative methods to improve and accelerate the drug development process and find new treatments for patients faster.

Repurposing Drugs

Discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside.

Testing & Predictive Models

Developing better model systems for drug and toxicity testing.

Core Technologies

Using state-of-the-art resources to enable the ongoing operation of all NCATS translational research activities.